Practical check-up guide
Insulin in China Check-up Lists: Different from Glucose and HbA1c
By MyChinaCheckup coordination team · Published
An insulin test measures a hormone. A glucose test measures blood sugar, and HbA1c provides a longer-term view of glucose exposure. These names cannot be substituted for one another when matching an existing test request to a China check-up list.
Across the 78 Shanghai and Guangzhou catalogue pages checked on 13 October 2026, ten explicitly name insulin. Six of those insulin rows say fasting, but only one expressly says serum. The original comparison below keeps those qualifiers attached to the correct measurement.
Three measurements, three separate entries
Insulin is made by the pancreas and helps glucose move from blood into cells. An insulin blood test measures the amount of that hormone. It is a different measurement from the glucose it helps regulate. MedlinePlus: insulin in blood.
A glucose measurement concerns blood sugar at the time of testing; HbA1c reflects average blood glucose over approximately three months. Those descriptions explain the measurements, not which tests a visitor should have. NIDDK: diabetes tests and diagnosis.
Scroll horizontally to see all columns.
| Name in an existing request | What the name identifies | What another row cannot establish |
|---|---|---|
| Insulin | The hormone measurement | A glucose or HbA1c entry does not confirm it |
| Fasting insulin | Insulin with a fasting qualifier | “Fasting glucose” elsewhere does not add this qualifier to an unqualified insulin row |
| Fasting serum insulin | Insulin, fasting and serum explicitly named | It does not specify an assay platform or a personalised preparation schedule |
| Glucose / fasting glucose | A glucose measurement, with fasting explicit only where written | It does not document an insulin result |
| HbA1c | Glycated haemoglobin | It does not document a separate insulin measurement |
What the ten insulin-containing lists actually say
The paired or grouped links share the displayed wording only; their complete packages are not necessarily identical. Numbering in the GMU rows is retained as a source locator, not part of the test name.
Scroll horizontally to see all columns.
| Catalogue package sources | Exact insulin item | Separate glucose item | Separate HbA1c item | Insulin specification established |
|---|---|---|---|---|
| Huashan Pudong: Men 01, Women 01 | Insulin | Fasting Blood Glucose (FBG) | Glycated haemoglobin (HbA1c) | Neither fasting nor specimen named in the insulin row |
| Huashan Pudong: Women 03 | Insulin | Fasting Blood Glucose | Glycated haemoglobin (HbA1c) | Neither fasting nor specimen named in the insulin row |
| Renji East: Men 01, Men 02, Men 03, Women 02, Women 03 | Fasting insulin | Fasting blood glucose | Glycated haemoglobin (HbA1c) | Fasting named; serum/plasma not identified in the insulin row |
| Nanfang: Women 03 | Insulin | Blood Glucose | Glycated haemoglobin (HbA1c) | Neither fasting nor specimen named in the insulin row |
| Guangzhou Medical University First Affiliated: Men 03 | 46. Fasting serum insulin measurement | 37. Fasting blood glucose | 33. Glycated haemoglobin (HbA1c) | Fasting and serum expressly named |
Six explicit fasting-insulin rows comprise the five Renji East lists and GMU Men 03. The four unqualified rows are Huashan Men 01, Women 01 and Women 03, plus Nanfang Women 03. That difference concerns documentation. It does not establish that the actual collection protocols differ, and it does not instruct anyone to eat or fast.
All ten lists separately name glucose and HbA1c as shown. Their co-occurrence does not combine them into one test or establish a clinical need for all three. In particular, Nanfang Women 03 writes “Blood Glucose” without a fasting qualifier in that item. It should not be silently relabelled fasting glucose when copying the comparison.
A nearby qualifier belongs to its own row
Huashan Women 03 also names “Fasting serum C-peptide” while its insulin row says only “Insulin”. The word serum and the fasting qualifier on C-peptide do not carry across to insulin. Renji East similarly writes fasting C-peptide and fasting insulin as separate rows. The source is identifying separate entries, not authorising a substitute.
This is a useful way to read any dense laboratory list: preserve the exact analyte and its own qualifiers before grouping related subjects. A section heading or the presence of a blood-collection service cannot resolve an unstated serum-versus-plasma specification for a particular assay.
Questions a visitor can get answered before booking
If a clinician has already requested an insulin measurement, send that exact wording alongside the proposed package URL. The useful questions are:
- Does the proposed laboratory order match the requested insulin measurement, including any stated specimen or assay requirements?
- Where the catalogue says only “Insulin”, what exact test name and specimen will appear in the accepted order and report?
- Does the request involve one measurement or a specified collection sequence? The bare catalogue name does not establish multiple timed samples or a tolerance-test protocol.
- Who will issue the appointment-specific preparation instructions and explain the results? A package label is not a fasting schedule or a promise of an endocrinology consultation.
A confirmed answer should distinguish the catalogue row, the laboratory order and any separately arranged service. Keep the clinician's original request intact if the provider proposes a different measurement. Do not resolve that difference by comparing package prices or treating a higher-numbered option as automatically more complete.
Can this list tell me whether I have insulin resistance?
No. This comparison establishes published test names and missing details, not a diagnosis from an insulin value. MedlinePlus describes insulin results as requiring clinical interpretation with other information. The article supplies no insulin-resistance calculation, result threshold, treatment adjustment or screening recommendation. MedlinePlus: interpreting insulin testing.
For the narrower distinction between glucose and HbA1c, see the existing glucose and HbA1c guide. The additional task here is to identify the separate insulin order and keep its fasting and specimen wording accurate.
Evidence and service limits
The comparison uses the complete public HTML item tables from 78 MyChinaCheckup package pages, with the ten matching pages linked above. All ten named insulin rows were refreshed on 13 October 2026. An unnamed panel elsewhere remains unresolved; absence of a named insulin row does not prove a hospital cannot supply the test. The audit does not independently verify current laboratory availability or reconcile a hospital-issued order with the operator's catalogue.
MyChinaCheckup can coordinate a specification enquiry and an accepted appointment. The healthcare provider determines clinical suitability, preparation and interpretation. Use Shanghai planning or Guangzhou planning for the visit context. An enquiry does not reserve a test or appointment.